Literature DB >> 21298276

Minimally invasive combined anterior kyphoplasty for osteolytic C2 and C5 metastases.

C Druschel1, K D Schaser, I Melcher, N P Haas, Alexander C Disch.   

Abstract

Kypho- and vertebroplasty are widely accepted for treating patients suffering from pathologic thoracolumbar lesions, in particular diffuse metastatic-induced fractures. They provide rapid pain relief and the restoration of spinal stability. In the cervical spine, attempts have been made to use cement augmentation for these indications. However, the cervical spine's anatomy complicates the transpedicular approach, as well as the pre-formation of a vertebral body cavity and the application of bone cement. We report the case of a 46-year-old woman suffering from symptomatic C2 and C5 osteolysis caused by metastatic breast cancer. Following a surgical staging and classification (Tokuhashi-Score) that indicated palliative procedures, we performed a C2 and C5 kyphoplasty using one minimal-invasive anterior approach through a small incision. We observed an uneventful procedure and postoperative course as well as immediate pain relief and patient mobilization. Last patient follow-up at 3 months showed an excellent outcome. Our observations showed cervical spine kyphoplasty via a minimally invasive anterior approach to be feasible, successful and safe surgical method in the interdisciplinary palliative treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21298276     DOI: 10.1007/s00402-011-1270-0

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  8 in total

1.  [Current status of vertebroplasty and kyphoplasty in Germany: an analysis of surgical disciplines].

Authors:  A Krüger; J Hierholzer; M Bergmann; L Oberkircher; S Ruchholtz
Journal:  Unfallchirurg       Date:  2013-09       Impact factor: 1.000

2.  Cervical vertebroplasty under sedoanalgesia using combined ultrasonography and fluoroscopy guidance: a novel technique.

Authors:  Serbülent Gökhan Beyaz; Havva Sayhan; Mustafa Erkan İnanmaz; Mustafa Orhan
Journal:  Eur Spine J       Date:  2017-09-08       Impact factor: 3.134

3.  [Role and limitations of vertebroplasty and kyphoplasty in the management of spinal metastases].

Authors:  M Akbar; M Eichler; S Hagmann; B Lehner; S Hemmer; C Kasperk; B Wiedenhöfer
Journal:  Orthopade       Date:  2012-08       Impact factor: 1.087

4.  Percutaneous vertebroplasty at C7 for the treatment of painful metastases -A case report-.

Authors:  Sung-Suk Seo; Dong-Heon Lee; Hae-Jin Kim; Ji-Wook Yoon; Oh-Sun Kwon; Kyung-Hoon Kim
Journal:  Korean J Anesthesiol       Date:  2013-03-19

5.  Corpectomy with adjacent-level kyphoplasty to treat metastatic lung cancer in three contiguous cervical vertebrae causing focal neurologic compromise.

Authors:  Antony H Bateman; Adam C Way
Journal:  Global Spine J       Date:  2014-08-21

6.  The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG).

Authors:  Charalampia Kyriakou; Sean Molloy; Frank Vrionis; Ronald Alberico; Leonard Bastian; Jeffrey A Zonder; Sergio Giralt; Noopur Raje; Robert A Kyle; David G D Roodman; Meletios A Dimopoulos; S Vincent Rajkumar; Brian B G Durie; Evangelos Terpos
Journal:  Blood Cancer J       Date:  2019-02-26       Impact factor: 11.037

7.  Combined Percutaneous Kyphoplasty/Pediculoplasty by Posterolateral Transpedicular Approach for Painful Cervical Spine Metastases: A Single-Center Prospective Study.

Authors:  Yonghui Xia; Huan Zhai; Xinlei Wang; Yudong Wang; Bo Feng
Journal:  J Pain Res       Date:  2021-06-10       Impact factor: 3.133

8.  Balloon kyphoplasty and additional anterior odontoid screw fixation for treatment of unstable osteolytic lesions of the vertebral body C2: a case series.

Authors:  Anna Voelker; Nicolas H von der Hoeh; Christoph-Eckhard Heyde
Journal:  BMC Musculoskelet Disord       Date:  2018-07-27       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.